AlereTM i Influenza A & B
NOW CLIA WAIVED!
Unique isothermal amplification technology
giving you molecular results, faster than
NEW AlereTM i
Influenza A & B
Molecular results in less than 15 minutes
AlereTM i gives you the confidence to make effective
clinical decisions sooner.
A positive impact
on your facility
Reliable near-patient testing
reduces overall healthcare costs1.
• Enables prompt initiation of infection control measures
• Connected results direct to your computer
• Facilitating effective patient management
Molecular sensitivity in an actionable timeframe means you can
withhold antibiotics and prescribe antivirals effectively.
the point of care
Intuitive and reliable, allowing you to respond
quickly and accurately in any setting.
1. Bonner, A.B. et al. Impact of the Rapid Diagnosis of Influenza on Physician
Decision-Making and Patient Management in the Pediatric Emergency
Department: Results of a Randomized, Prospective, Controlled Trial.
Pediatrics. 2003 Vol. 112 No. 2.